ImmunoIVD AB Sustainability Reports
ImmunoIVD AB develops and provides molecular screening assays and diagnostic kits for routine newborn screening of rare genetic diseases, such as severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA).
Sector: Professional & technical services
Country: Sweden
Exchange: Unlisted
LEI: 984500A4C9DD707A0O18
2 reports from 2025 to 2025
